Clinical Research Directory

Inclusion Criteria: * 18.0 - 74.9 years of age * Participant-reported diagnosis of type 2 diabetes * HbA1c 7.0%-11% (inclusive) * Overweight or obesity (BMI 25-50 kg/m2) * On stable regimen of medications that can affect weight or diabetes outcomes for at least 3 months (brief regimens of medications such as antibiotics, steroids, etc. are permitted) * Willingness to attend weekly WW Virtual Workshops and participate in WW Digital program * Access to a smartphone/tablet that can download the WW app * Willing and able to provide a valid email address for use in the study * Be able to communicate (oral and written) in English * Be under the care of a physician who will be responsible for managing the subject's diabetes and a participant who is willing to give release to provide their treating MD with information about the trial * Be able to provide informed consent Exclusion Criteria: * Participation in a weight control program within the past 3 months * Weight loss of ≥ 5 kg in the previous 6 months * Taking prescription or over-the-counter weight loss medications within last 3 months * History of weight loss surgery * History of major surgery within three months of enrollment * Type 1 diabetes * Renal insufficiency consisting of potassium over 5.5 mmol/L on a non-hemolyzed specimen, or a creatinine \> 2.5 mg/dL * Albumin \< 3 g/dL * Alanine Aminotransferase \> 3 times the upper limit of normal (normal range is 7-56 IU/L) * More than 1 severe hypoglycemic event (requiring emergency medical services) in the past 12 months, unless the participant's physician provides written clearance for participation * Hemoglobinopathy that interferes with measurement of HbA1c * Class II or higher congestive heart failure * Unstable heart disease (an ongoing workup or treatment for a cardiac symptom such as unstable angina, coronary ischemia) * Presence of implanted cardiac defibrillator * Blood pressure ≥160/100 mm Hg. If a potential participant has a blood pressure ≥160/100 mm Hg it is acceptable to re-test this potential participant within one week of the original test * Thyroid disease for which the participant is untreated or has had treatment changed within the last 6 months. History of thyroid disease or current thyroid disease treated with a stable medication regimen for at least 2 months is acceptable * Orthopedic limitations that would interfere with ability to engage in regular physical activity * Uncontrolled gastrointestinal disorders including chronic malabsorptive conditions, peptic ulcer disease, Crohn's disease, chronic diarrhea or active gallbladder disease * Current cancer or cancer treatment, or a history of cancer or cancer treatment within the last 3 years. Persons with successfully resected non-melanoma carcinoma of the skin may be enrolled * Dementia, psychiatric illness, or substance abuse that may interfere with adherence (e.g., illness that is currently unstable or resistant to first-line therapy; substance abuse in the past year) * History of clinically diagnosed eating disorder including anorexia nervosa or bulimia nervosa. * Women who are pregnant, lactating, trying to become pregnant or unwilling to use an effective means of birth control * Currently consuming \>14 alcoholic drinks (1 drink = 12 fl oz beer, 4 fl oz wine or 1.5 fl oz liquor) per week and unwilling to limit intake to less than 3 drinks per day during study participation * Participation in another clinical trial within 30 days prior to enrollment * Participation in WW anytime since November 2021 * Any other condition or factor which in the opinion of the study physician or investigator makes it inadvisable for the candidate to participate in the trial